Functional Fluidics

Functional Fluidics is a Detroit-based, privately-held diagnostics and contract research company that has developed a proprietary suite of functional assays to assess red blood cell health. Operating a CLIA-certified lab, it serves pharmaceutical partners, academic institutions, and clinicians by providing critical biomarker data for drug development and personalized patient management, particularly in sickle cell disease. The company is expanding its geographic footprint with a new lab in Nigeria and is actively engaging with investors to support its growth. Its business model combines diagnostic testing services with a specialized CRO offering, positioning it at the intersection of precision diagnostics and therapeutic development for hematologic conditions.

A suite of proprietary, functional cell-based assays that measure red blood cell health under physiological stress, including Flow Adhesion, Dynamic Sickling, and Mechanical Fragility assays. These provide quantitative biomarkers for disease severity, drug mechanism, and product quality.

Functional Fluidics occupies a specialized niche with few direct competitors offering the same breadth of functional RBC assays. It competes with large, generalist CROs (e.g., LabCorp, IQVIA) on service and academic core labs on innovation. Its main competitive advantage is its proprietary, validated assay suite and CLIA certification, allowing it to serve both research and clinical markets. New entrants would face significant technical and regulatory hurdles.